Simulations Plus, Inc. (NASDAQ:SLP) Receives $56.00 Consensus PT from Brokerages

Simulations Plus, Inc. (NASDAQ:SLP) has been assigned an average recommendation of “Moderate Buy” from the five brokerages that are presently covering the stock, Marketbeat reports. One research analyst has rated the stock with a hold rating and four have issued a buy rating on the company. The average 12 month target price among brokerages that have issued a report on the stock in the last year is $56.00.

A number of research firms recently issued reports on SLP. Craig Hallum restated a “buy” rating and set a $56.00 target price on shares of Simulations Plus in a research report on Wednesday, July 3rd. KeyCorp began coverage on shares of Simulations Plus in a research note on Monday, July 29th. They issued an “overweight” rating and a $47.00 price target on the stock. William Blair reaffirmed an “outperform” rating on shares of Simulations Plus in a research note on Thursday, September 12th. JMP Securities initiated coverage on Simulations Plus in a research note on Tuesday, July 16th. They issued a “market perform” rating on the stock. Finally, Oppenheimer lifted their target price on shares of Simulations Plus from $55.00 to $65.00 and gave the company an “outperform” rating in a report on Thursday, June 13th.

Insider Buying and Selling

In other news, Director Walter S. Woltosz sold 20,000 shares of the stock in a transaction dated Monday, July 1st. The shares were sold at an average price of $46.71, for a total transaction of $934,200.00. Following the transaction, the director now directly owns 3,540,857 shares in the company, valued at approximately $165,393,430.47. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. In related news, Director Daniel L. Weiner sold 750 shares of Simulations Plus stock in a transaction on Friday, June 28th. The shares were sold at an average price of $49.32, for a total value of $36,990.00. Following the completion of the sale, the director now owns 7,009 shares in the company, valued at $345,683.88. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Walter S. Woltosz sold 20,000 shares of the business’s stock in a transaction on Monday, July 1st. The shares were sold at an average price of $46.71, for a total transaction of $934,200.00. Following the sale, the director now owns 3,540,857 shares of the company’s stock, valued at approximately $165,393,430.47. The disclosure for this sale can be found here. In the last quarter, insiders sold 60,750 shares of company stock worth $2,467,390. 20.90% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Simulations Plus

Several institutional investors have recently modified their holdings of SLP. EntryPoint Capital LLC acquired a new position in shares of Simulations Plus during the first quarter worth approximately $57,000. Allspring Global Investments Holdings LLC bought a new position in Simulations Plus in the 1st quarter valued at about $70,000. Los Angeles Capital Management LLC bought a new stake in shares of Simulations Plus during the 2nd quarter worth about $206,000. Arizona State Retirement System bought a new stake in Simulations Plus during the second quarter worth approximately $218,000. Finally, Connecticut Wealth Management LLC bought a new position in Simulations Plus during the 1st quarter valued at $204,000. Institutional investors own 78.08% of the company’s stock.

Simulations Plus Trading Up 2.6 %

Shares of SLP opened at $32.26 on Tuesday. The company has a market cap of $645.52 million, a P/E ratio of 67.21 and a beta of 0.70. Simulations Plus has a twelve month low of $31.41 and a twelve month high of $51.22. The company’s fifty day simple moving average is $37.04 and its 200-day simple moving average is $42.68.

Simulations Plus (NASDAQ:SLP) last issued its earnings results on Tuesday, July 2nd. The technology company reported $0.19 earnings per share for the quarter, topping the consensus estimate of $0.15 by $0.04. The business had revenue of $18.54 million during the quarter, compared to analysts’ expectations of $17.92 million. Simulations Plus had a return on equity of 7.80% and a net margin of 14.36%. The business’s revenue for the quarter was up 14.2% compared to the same quarter last year. During the same period in the prior year, the business earned $0.20 EPS. Analysts predict that Simulations Plus will post 0.51 earnings per share for the current fiscal year.

Simulations Plus Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, August 5th. Shareholders of record on Monday, July 29th were issued a $0.06 dividend. This represents a $0.24 annualized dividend and a dividend yield of 0.74%. The ex-dividend date of this dividend was Monday, July 29th. Simulations Plus’s dividend payout ratio (DPR) is presently 50.00%.

About Simulations Plus

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.